Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy

INTRODUCTION: The integrase strand transfer inhibitor dolutegravir (DTG) has a high genetic barrier to resistance. Only rare cases of resistance to DTG have been reported when it is used as a component of antiretroviral therapy regimens in treatment-experienced patients unless there was prior use of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:South Afr J HIV Med
Asıl Yazarlar: Mahomed, Kairoonisha, Wallis, Carole L., Dunn, Liezl, Maharaj, Shavani, Maartens, Gary, Meintjes, Graeme
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AOSIS 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7433307/
https://ncbi.nlm.nih.gov/pubmed/32832110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4102/sajhivmed.v21i1.1062
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller